{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:26:44Z","timestamp":1785252404895,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Foundation of Minhang District, Shanghai","award":["2023MHZ070"],"award-info":[{"award-number":["2023MHZ070"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"DOI":"10.1007\/s12105-025-01853-4","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:06:21Z","timestamp":1761714381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["NUT Carcinoma of the Head and Neck: Clinicopathologic and Molecular Analysis of 18 Cases"],"prefix":"10.1007","volume":"19","author":[{"given":"Yifeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuncun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"20","key":"1853_CR1","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1200\/jco.2004.02.107","volume":"22","author":"CA French","year":"2004","unstructured":"French CA, Kutok JL, Faquin WC et al (2004) Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 22(20):4135\u20134139. https:\/\/doi.org\/10.1200\/jco.2004.02.107","journal-title":"J Clin Oncol"},{"issue":"12","key":"1853_CR2","first-page":"3327","volume":"51","author":"I Kubonishi","year":"1991","unstructured":"Kubonishi I, Takehara N, Iwata J et al (1991) Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res 51(12):3327\u20133328","journal-title":"Cancer Res"},{"issue":"4","key":"1853_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/00043426-199124000-00011","volume":"13","author":"UR Kees","year":"1991","unstructured":"Kees UR, Mulcahy MT, Willoughby ML (1991) Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19). Am J Pediatr Hematol\/Oncol 13(4):459\u2013464. https:\/\/doi.org\/10.1097\/00043426-199124000-00011","journal-title":"Am J Pediatr Hematol\/Oncol"},{"issue":"2","key":"1853_CR4","first-page":"304","volume":"63","author":"CA French","year":"2003","unstructured":"French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA (2003) BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 63(2):304\u2013307","journal-title":"Cancer Res"},{"issue":"11","key":"1853_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/pin.12727","volume":"68","author":"CA French","year":"2018","unstructured":"French CA (2018) NUT carcinoma: clinicopathologic features, pathogenesis, and treatment. Pathol Int 68(11):583\u2013595. https:\/\/doi.org\/10.1111\/pin.12727","journal-title":"Pathol Int"},{"issue":"9","key":"1853_CR6","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/jto.0000000000000630","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Nicholson AG et al (2015) The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J thorac oncol Offi Publ Int Assoc Study Lung Cancer 10(9):1243\u20131260. https:\/\/doi.org\/10.1097\/jto.0000000000000630","journal-title":"J thorac oncol Offi Publ Int Assoc Study Lung Cancer"},{"issue":"2","key":"1853_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/pas.0000000000001774","volume":"46","author":"A Agaimy","year":"2022","unstructured":"Agaimy A, Haller F, Renner A, Niedermeyer J, Hartmann A, French CA (2022) Misleading germ cell phenotype in pulmonary NUT carcinoma harboring the ZNF532-NUTM1 fusion. Am J Surg Pathol 46(2):281\u2013288. https:\/\/doi.org\/10.1097\/pas.0000000000001774","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1853_CR8","doi-asserted-by":"publisher","first-page":"pkz094","DOI":"10.1093\/jncics\/pkz094","volume":"4","author":"NG Chau","year":"2020","unstructured":"Chau NG, Ma C, Danga K et al (2020) An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients. JNCI Cancer Spectr 4(2):pkz094. https:\/\/doi.org\/10.1093\/jncics\/pkz094","journal-title":"JNCI Cancer Spectr"},{"issue":"20","key":"1853_CR9","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1158\/1078-0432.Ccr-12-1153","volume":"18","author":"DE Bauer","year":"2012","unstructured":"Bauer DE, Mitchell CM, Strait KM et al (2012) Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res 18(20):5773\u20135779. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-1153","journal-title":"Clin Cancer Res"},{"issue":"23","key":"1853_CR10","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1002\/cncr.30242","volume":"122","author":"NG Chau","year":"2016","unstructured":"Chau NG, Hurwitz S, Mitchell CM et al (2016) Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck. Cancer 122(23):3632\u20133640. https:\/\/doi.org\/10.1002\/cncr.30242","journal-title":"Cancer"},{"issue":"1","key":"1853_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13000-024-01466-5","volume":"19","author":"C Hu","year":"2024","unstructured":"Hu C, Lin L, Ye M et al (2024) Re-evaluating a historic cohort of sinonasal and skull base mucoepidermoid carcinoma: an institutional experience. Diagn Pathol 19(1):46. https:\/\/doi.org\/10.1186\/s13000-024-01466-5","journal-title":"Diagn Pathol"},{"issue":"7","key":"1853_CR12","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/PAS.0b013e318198d666","volume":"33","author":"H Haack","year":"2009","unstructured":"Haack H, Johnson LA, Fry CJ et al (2009) Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 33(7):984\u2013991. https:\/\/doi.org\/10.1097\/PAS.0b013e318198d666","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"1853_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/pai.0000000000001095","volume":"31","author":"P Price","year":"2023","unstructured":"Price P, Ganugapati U, Gatalica Z et al (2023) Reinventing nuclear Histo-score utilizing inherent morphologic cutoffs: blue-brown color H-score (BBC-HS). Appl Immunohistochem Mol Morphol 31(7):500\u2013506. https:\/\/doi.org\/10.1097\/pai.0000000000001095","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"9","key":"1853_CR14","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jtho.2018.05.013","volume":"13","author":"MS Tsao","year":"2018","unstructured":"Tsao MS, Kerr KM, Kockx M et al (2018) PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of blueprint phase 2 project. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 13(9):1302\u20131311. https:\/\/doi.org\/10.1016\/j.jtho.2018.05.013","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"1853_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ajo.2022.03.008","volume":"239","author":"H Sun","year":"2022","unstructured":"Sun H, Cai R, Zhai C, Song W, Sun J, Bi Y (2022) Primary mucoepidermoid carcinoma of the lacrimal apparatus. Am J Ophthalmol 239:170\u2013179. https:\/\/doi.org\/10.1016\/j.ajo.2022.03.008","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"1853_CR16","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41379-019-0206-z","volume":"32","author":"TM Stevens","year":"2019","unstructured":"Stevens TM, Morlote D, Xiu J et al (2019) NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum. Mod Pathol 32(6):764\u2013773. https:\/\/doi.org\/10.1038\/s41379-019-0206-z","journal-title":"Mod Pathol"},{"issue":"5","key":"1853_CR17","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00428-021-03224-0","volume":"480","author":"J Liu","year":"2022","unstructured":"Liu J, Mao R, Lao IW et al (2022) GLI1-altered mesenchymal tumor: a clinicopathological and molecular analysis of ten additional cases of an emerging entity. Virchows Archiv Int J Pathol 480(5):1087\u20131099. https:\/\/doi.org\/10.1007\/s00428-021-03224-0","journal-title":"Virchows Archiv Int J Pathol"},{"issue":"6","key":"1853_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/jcp.2007.052902","volume":"63","author":"CA French","year":"2010","unstructured":"French CA (2010) Demystified molecular pathology of NUT midline carcinomas. J Clin Pathol 63(6):492\u2013496. https:\/\/doi.org\/10.1136\/jcp.2007.052902","journal-title":"J Clin Pathol"},{"key":"1853_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.102826","volume":"144","author":"M Salati","year":"2019","unstructured":"Salati M, Baldessari C, Bonetti LR et al (2019) Nut midline carcinoma: current concepts and future perspectives of a novel tumour entity. Crit Rev Oncol Hematol 144:102826. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.102826","journal-title":"Crit Rev Oncol Hematol"},{"key":"1853_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.lungcan.2021.06.008","volume":"158","author":"A Fekkar","year":"2021","unstructured":"Fekkar A, Emprou C, Lefebvre C et al (2021) Thoracic NUT carcinoma: common pathological features despite diversity of clinical presentations. Lung cancer (Amst Neth) 158:55\u201359. https:\/\/doi.org\/10.1016\/j.lungcan.2021.06.008","journal-title":"Lung cancer (Amst Neth)"},{"key":"1853_CR21","doi-asserted-by":"publisher","unstructured":"Chau NG, Ma C, Danga K, et al. (2018) A novel prognostic risk classification model for NUT midline carcinoma: a largest cohort analysis from the NMC registry.36(15_suppl):6085\u20136085. https:\/\/doi.org\/10.1200\/JCO.2018.36.15_suppl.6085","DOI":"10.1200\/JCO.2018.36.15_suppl.6085"},{"issue":"2","key":"1853_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/his.15204","volume":"85","author":"K Viswanathan","year":"2024","unstructured":"Viswanathan K, Hahn E, Dogan S et al (2024) The histological spectrum and immunoprofile of head and neck NUT carcinoma: A multicentre series of 30 cases. Histopathology 85(2):317\u2013326. https:\/\/doi.org\/10.1111\/his.15204","journal-title":"Histopathology"},{"issue":"2","key":"1853_CR23","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s12105-020-01220-5","volume":"15","author":"AC McLean-Holden","year":"2021","unstructured":"McLean-Holden AC, Moore SA, Gagan J et al (2021) NUT carcinoma in a patient with unusually long survival and false negative FISH results. Head Neck Pathol 15(2):698\u2013703. https:\/\/doi.org\/10.1007\/s12105-020-01220-5","journal-title":"Head Neck Pathol"},{"issue":"2","key":"1853_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/his.15023","volume":"84","author":"T Kervarrec","year":"2024","unstructured":"Kervarrec T, Pissaloux D, Tirode F et al (2024) Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: an update. Histopathology 84(2):266\u2013278. https:\/\/doi.org\/10.1111\/his.15023","journal-title":"Histopathology"},{"issue":"9","key":"1853_CR25","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1172\/jci126185","volume":"129","author":"S Sekine","year":"2019","unstructured":"Sekine S, Kiyono T, Ryo E et al (2019) Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma. J Clin Invest 129(9):3827\u20133832. https:\/\/doi.org\/10.1172\/jci126185","journal-title":"J Clin Invest"},{"issue":"5","key":"1853_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/pas.0000000000001021","volume":"42","author":"BC Dickson","year":"2018","unstructured":"Dickson BC, Sung YS, Rosenblum MK et al (2018) NUTM1 gene fusions characterize a subset of undifferentiated soft tissue and visceral tumors. Am J Surg Pathol 42(5):636\u2013645. https:\/\/doi.org\/10.1097\/pas.0000000000001021","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"1853_CR27","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/pas.0000000000002254","volume":"48","author":"P Zhu","year":"2024","unstructured":"Zhu P, Sun K, Lao IW et al (2024) Expanding the spectrum of NUTM1-rearranged sarcoma: a clinicopathologic and molecular genetic study of 8 cases. Am J Surg Pathol 48(8):930\u2013941. https:\/\/doi.org\/10.1097\/pas.0000000000002254","journal-title":"Am J Surg Pathol"},{"issue":"50","key":"1853_CR28","doi-asserted-by":"publisher","first-page":"E11711","DOI":"10.1073\/pnas.1814397115","volume":"115","author":"JF Li","year":"2018","unstructured":"Li JF, Dai YT, Lilljebj\u00f6rn H et al (2018) Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. Proc Natl Acad Sci USA 115(50):E11711-e11720. https:\/\/doi.org\/10.1073\/pnas.1814397115","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1853_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/hed.27553","volume":"46","author":"U Ramesh","year":"2024","unstructured":"Ramesh U, Contrera KJ, Shakibai N et al (2024) Sinonasal NUT carcinoma: a consecutive case series and systematic review. Head Neck 46(1):29\u201336. https:\/\/doi.org\/10.1002\/hed.27553","journal-title":"Head Neck"},{"issue":"5","key":"1853_CR30","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jtho.2023.12.022","volume":"19","author":"J Luo","year":"2024","unstructured":"Luo J, Sanchez M, Lee E et al (2024) Initial chemotherapy for locally advanced and metastatic NUT carcinoma. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 19(5):829\u2013838. https:\/\/doi.org\/10.1016\/j.jtho.2023.12.022","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"8","key":"1853_CR31","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/s41388-020-01625-0","volume":"40","author":"KP Eagen","year":"2021","unstructured":"Eagen KP, French CA (2021) Supercharging BRD4 with NUT in carcinoma. Oncogene 40(8):1396\u20131408. https:\/\/doi.org\/10.1038\/s41388-020-01625-0","journal-title":"Oncogene"},{"issue":"12","key":"1853_CR32","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1016\/j.celrep.2017.08.082","volume":"20","author":"J Br\u00e4gelmann","year":"2017","unstructured":"Br\u00e4gelmann J, Dammert MA, Dietlein F et al (2017) Systematic kinase inhibitor profiling identifies CDK9 as a synthetic lethal target in NUT midline carcinoma. Cell Rep 20(12):2833\u20132845. https:\/\/doi.org\/10.1016\/j.celrep.2017.08.082","journal-title":"Cell Rep"},{"issue":"8","key":"1853_CR33","doi-asserted-by":"publisher","first-page":"e740","DOI":"10.1634\/theoncologist.2018-0477","volume":"24","author":"M Jung","year":"2019","unstructured":"Jung M, Kim S, Lee JK et al (2019) Clinicopathological and preclinical findings of NUT carcinoma: a multicenter study. Oncologist 24(8):e740\u2013e748. https:\/\/doi.org\/10.1634\/theoncologist.2018-0477","journal-title":"Oncologist"},{"issue":"13_Supplement","key":"1853_CR34","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1158\/1538-7445.AM2019-1191","volume":"79","author":"LM Rooper","year":"2019","unstructured":"Rooper LM, London NR, Taube JM, Westra WH, Bishop JA, Kang H (2019) Abstract 1191: PD-L1 expression and the tumor immune microenvironment in NUT carcinoma. Cancer Res 79(13_Supplement):1191\u20131191. https:\/\/doi.org\/10.1158\/1538-7445.AM2019-1191","journal-title":"Cancer Res"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-025-01853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-025-01853-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-025-01853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T04:53:42Z","timestamp":1767588822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-025-01853-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1853"],"URL":"https:\/\/doi.org\/10.1007\/s12105-025-01853-4","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all participants, or from a parent and\/or legal guardian for participants under 16\u00a0years of age.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent for the publication of clinical details and any accompanying images was obtained from all participants (or from their parent or legal guardian in the case of minors).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The current study was approved by the Ethics Committee of the Eye & ENT Hospital of Fudan University and performed in strict accordance with the Declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"122"}}